Immunopotentiators in Modern Vaccines

7-9 May 2014, Sao Rafael Atlantic Hotel, Albufeira, Algarve, Portugal

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Wednesday 7th May

10.00-11.00
Registration & Coffee

SESSION 1:
PLENARY SESSION

Moderator: James Brewer (University of Glasgow, Glasgow, UK)

11.00-11.20
‘Welcome and introduction to Immunopotentiators in Modern Vaccines’
Virgil Schijns (Wageningen University, Wageningen, The Netherlands)

11.20-11.50
‘What is the next generation of adjuvant?’

Derek O’Hagan (Novartis Vaccines & Diagnostics, Cambridge, Massachusetts, USA)

11.50-12.20
‘Adjuvants: Where they go, what they do and how they do it’

Jim Brewer (University of Glasgow, Glasgow, UK)

12.20-12.50
‘Re-thinking vaccinology’
Geert Vanden Bossche (Univac LLC, Belgium)

12.50-14.00
Lunch Break
Seven Seas Restaurant

SESSION 2:
MUCOSAL

Moderator: Geert Vanden Bossche (Univac LLC, Belgium)

14.00-14.30
‘Immunopotentiators for mucosal immunity’
Ali Harandi (University of Gothenburg, Gothenburg, Sweden)

14.30-14.50
‘Intranasally administered Endocine™ formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets’
Koert J. Stittelaar, Anna-Karin Maltais, Edwin J.B. Veldhuis Kroeze, Geert van Amerongen, leon de Waal, Marcle L. Dijkshoorn, Gabriel P. Krestin, Jorma Hinkula, Hans Arwidsson, Alf Lindberg and Albert D.M.E. Osterhaus (Viroclinics Biosciences, Rotterdam, The Netherlands)

14.50-15.10
‘Triterpen saponins of plant origin as an efficient immunopotentiators for mucosal immunization’
V.E. Berezin, A.P. Bogoyavlenskyi, P.G. Alexyuk and I.A. Zaitceva (Institute of Mcrobiology and Virology, Almaty, Kazakhstan)

15.10-15.40
‘An intranasal proteosomes vaccine: An update’
Rob Lambkin-Williams (Retroscreen Virology Ltd, London, UK)

15.40-16.10
Tea Break

SESSION 3:
ADJUVANTS I

Moderator: Dennis Christensen (Statens Serum Institut, Copenhagen, Denmark)

16.10-16.40
‘Adjuvant comparison across models through system vaccinology’
Arnaud Didierlaurent (GSK Vaccines, Rixensart, Belgium)

16.40-16.55
‘CAF01: A safe and effective liposome adjuvant that promotes strong and long-lived antigen specific T cell responses in humans’
Dennis Christensen (Statens Serum Institut, Copenhagen, Denmark)

16.55-17.20
’Evaluation of new adjuvant components in vitro may lead to false-negative conclusions: A study on synthetic MMG analogues’
Karen Smith Korsholm (Statens Serum Institut, Copenhagen, Denmark) & Birte Martin-Bertelsen (University of Copenhagen, Copenhagen, Denmark)

17.20-17.40
‘Influence of the molecular structure of mono and diester analogues of trehalose-6,6' -dibehenate (TBD) on biophysical characteristics and receptor interaction with Mincle’
Rie Selchau Kallerup, Birte Martin-Bertelsen, Henrik Franzyk, Ana Yanhmur, Dennis Christensen, Karen Smith Korsholm, Alexandra Huber, Roland Lang and Camilla Foged (University of Copenhagen, Copenhagen, Denmark)

17.40-18.30
IMV 2014 Welcome Reception
Will be held in the Chill-Out Bar

 

IMV 2014 Delegates

Login details will be supplied after you have registered for the event.


IMV 2014 Sponsors

  • Abivax
  • European Adjuvant Advisory Committee
  • Univac
  • Immune Design
  • Sanofi Pasteur
  • Brenntag
  • Eurocine Vaccines
  • DNAvaccine.com
  • Novartis Vaccines
  • Aldevron
  • NatureGeneTherapy
  • Pfizer
  • Viscogel
  • Seppic
  • Mucosis
  • Inovio Pharmaceuticals
  • Infectious Disease Research Institute
  • Dynavax Technologies

IMV 2014 Downloads

IMV 2014 Leaflet

IMV 2014 Mailing List

Name
E-mail Address
What is 2+6-2?